Effects of caffeic acid on learning deficits in a model of Alzheimer's disease

International Journal of Molecular Medicine

Volumn 38, Issue 3, 2016, Pages 869-875

  Wang, Yunliang ^a   Wang, Yutong ^b   Li, Jinfeng ^a   Hua, Linlin ^c   Han, Bing ^a   Zhang, Yuzhen ^a   Yang, Xiaopeng ^c   Zeng, Zhilei ^c   Bai, Hongying ^c   Yin, Honglei ^a   Lou, Jiyu ^c  

^a The 148 Central Hospital of PLA   (China)

^b HENAN UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Caffeic acid; Learning deficits

Indexed keywords

ACETYLCHOLINESTERASE; CAFFEIC ACID; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRITE; PROTEIN P53; TRANSCRIPTION FACTOR RELA; CAFFEIC ACID DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; LEARNING DISORDER; MALE; MORRIS WATER MAZE TEST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TASK PERFORMANCE; ANIMAL; BRAIN; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; INFLAMMATION; LEARNING DISORDERS; MAZE TEST; METABOLISM; PHOSPHORYLATION; RANDOMIZATION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ACETYLCHOLINESTERASE; ALZHEIMER DISEASE; ANIMALS; BLOTTING, WESTERN; BRAIN; CAFFEIC ACIDS; CASPASE 3; COGNITION; DISEASE MODELS, ANIMAL; INFLAMMATION; LEARNING DISORDERS; MALE; MAZE LEARNING; NITRITES; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84979902304     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2683     Document Type: Article

References (28)

1. Muir SW, Speechley M, Wells J, Borrie M, Gopaul K and MonteroOdasso M: Gait assessment in mild cognitive impairment and Alzheimer's disease: the effect of dualtask challenges across the cognitive spectrum. Gait Posture 35: 96-100, 2012.
2. Pitkala KH, Raivio MM, Laakkonen ML, Tilvis RS, Kautiainen H and Strandberg TE: Exercise rehabilitation on home-dwelling patients with Alzheimer's disease-a randomized, controlled trial. Study protocol. Trials 11: 92, 2010.
3. SpiresJones TL, Mielke ML, Rozkalne A, MeyerLuehmann M, de Calignon A, Bacskai BJ, Schenk D and Hyman BT: Passive immunotherapy rapidly increases structural plasticity in a mouse model of Alzheimer disease. Neurobiol Dis 33: 213-220, 2009.
4. Olazarán J, Reisberg B, Clare L, Cruz I, PeñaCasanova J, Del Ser T, Woods B, Beck C, Auer S, Lai C, et al: Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord 30: 161-178, 2010.
5. Wang WY, Tan MS, Yu JT and Tan L: Role of proinflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med 3: 136, 2015.
6. Götz J, Ittner LM, Schonrock N and Cappai R: An update on the toxicity of Abeta in Alzheimer's disease. Neuropsychiatr Dis Treat 4: 1033-1042, 2008.
7. Pittalà V, Salerno L, Romeo G, Siracusa MA, Modica MN, Romano GL, Salomone S, Drago F and Bucolo C: Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation. Eur J Pharmacol 752: 78-83, 2015.
8. Pinho E, Henriques M and Soares G: Caffeic acid loading wound dressing: Physicochemical and biological characterization. Ther Deliv 5: 1063-1075, 2014.
9. Tanida I, Shirasago Y, Suzuki R, Abe R, Wakita T, Hanada K and Fukasawa M: Inhibitory effects of caffeic acid, a coffeerelated organic acid, on the propagation of hepatitis C virus. Jpn J Infect Dis 68: 268-275, 2015.
10. Paracatu LC, Faria CM, Quinello C, Rennó C, Palmeira P, Zeraik ML, da Fonseca LM and Ximenes VF: Caffeic Acid phenethyl ester: consequences of its hydrophobicity in the oxidative functions and cytokine release by leukocytes. Evid Based Complement Alternat Med 2014: 793629, 2014.
11. Bailly F and Cotelle P: AntiHIV activities of natural antioxidant caffeic acid derivatives: toward an antiviral supplementation diet. Curr Med Chem 12: 1811-1818, 2005.
12. Yang Y, Li Y, Wang K, Wang Y, Yin W and Li L: P38/NFB/snail pathway is involved in caffeic acidinduced inhibition of cancer stem cellslike properties and migratory capacity in malignant human keratinocyte. PLoS One 8: e58915, 2013.
13. Ellman GL, Courtney KD, Andres V Jr and FeatherStone RM: A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95, 1961.
14. Paillard T, Rolland Y and de Souto Barreto P: Protective effects of physical exercise in Alzheimer's disease and Parkinson's disease: a narrative review. J Clin Neurol 11: 212-219, 2015.
15. Xu H, Finkelstein Di and Adlard PA: Interactions of metals and Apolipoprotein E in Alzheimer's disease. Front Aging Neurosci 6: 121, 2014.
16. Khan KA, Kumar N, Nayak PG, Nampoothiri M, Shenoy RR, Krishnadas N, Rao CM and Mudgal J: Impact of caffeic acid on aluminium chlorideinduced dementia in rats. J Pharm Pharmacol 65: 1745-1752, 2013.
17. Pinheiro Fernandes FD, Fontenele Menezes AP, de Sousa Neves JC, Fonteles AA, da Silva AT, de Araújo Rodrigues P, Santos do Carmo MR, de Souza CM and de Andrade GM: Caffeic acid protects mice from memory deficits induced by focal cerebral ischemia. Behav Pharmacol 25: 637-647, 2014.
18. Yousof Ali M, Jung HA and Choi JS: Antidiabetic and antiAlzheimer's disease activities of Angelica decursiva. Arch Pharm Res 38: 2216-2227, 2015.
19. Zimmermann M: Neuronal AChE splice variants and their nonhydrolytic functions: redefining a target of AChE inhibitors Br J Pharmacol 170: 953-967, 2013.
20. Mehrotra A, Shanbhag R, Chamallamudi MR, Singh VP and Mudgal J: Ameliorative effect of caffeic acid against inflammatory pain in rodents. Eur J Pharmacol 666: 80-86, 2011.
21. Sassi C, Ridge PG, Nalls MA, Gibbs R, Ding J, Lupton MK, Troakes C, Lunnon K, Al-Sarraj S, Brown KS, et al: Influence of coding variability in APP-A metabolism genes in sporadic Alzheimer's disease. PLoS One 11: e0150079, 2016.
22. Gonzalez P, da Costa VC, Hyde K, Wu Q, Annunziata O, Rizo J, Akkaraju G and Green KN: Bimodalhybrid heterocyclic amine targeting oxidative pathways and copper misregulation in Alzheimer's disease. Metallomics 6: 2072-2082, 2014.
23. Hatanaka H, Hanyu H, Hirose D, Fukusawa R, Namioka N and Iwamoto T: Peripheral oxidative stress markers in individuals with Alzheimer's disease with or without cerebrovascular disease. J Am Geriatr Soc 63: 1472-1474, 2015.
24. Kim H, Kim W, Yum S, Hong S, Oh JE, Lee JW, Kwak MK, Park EJ, Na DH and Jung Y: Caffeic acid phenethyl ester activation of Nrf2 pathway is enhanced under oxidative state: structural analysis and potential as a pathologically targeted therapeutic agent in treatment of colonic inflammation. Free Radic Biol Med 65: 552-562, 2013.
25. Ashabi G, Alamdary SZ, Ramin M and Khodagholi F: Reduction of hippocampal apoptosis by intracerebroventricular administration of extracellular signalregulated protein kinase and/or p38 inhibitors in amyloid beta rat model of Alzheimer's disease: involvement of nuclearrelated factor2 and nuclear factorB. Basic Clin Pharmacol Toxicol 112: 145-155, 2013.
26. Yang WN, Ma KG, Qian YH, Zhang JS, Feng GF, Shi LL, Zhang ZC and Liu ZH: Mitogenactivated protein kinase signaling pathways promote lowdensity lipoprotein receptorrelated protein 1mediated internalization of betaamyloid protein in primary cortical neurons. Int J Biochem Cell Biol 64: 252-264, 2015.
27. Kim TI, Lee YK, Park SG, Choi IS, Ban JO, Park HK, Nam SY, Yun YW, Han SB, Oh KW and Hong JT: LTheanine, an amino acid in green tea, attenuates betaamyloidinduced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NFkappaB pathways. Free Radic Biol Med 47: 1601-1610, 2009.
28. Lee MS, Kim YH, Lee BR, Kwon SH, Moon WJ, Hong KS, Song YS, Morita K, Hahm DH, Shim I and Her S: Novel antidepressantlike activity of caffeic acid phenethyl ester is mediated by enhanced glucocorticoid receptor function in the hippocampus. Evid Based Complement Alternat Med 2014: 646039, 2014.